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Background: Alcohol consumption is a major global risk factor for mortality and morbidity. Much discussion has
revolved around the diverse findings on the complex relationship between alcohol consumption and the leading
cause of death and disability, ischemic heart disease (IHD).
Methods: We conducted a systematic search of the literature up to August 2014 using Preferred Reporting Items
for Systematic Reviews and Meta-Analyses guidelines to identify meta-analyses and observational studies examining
the relationship between alcohol drinking, drinking patterns, and IHD risk, in comparison to lifetime abstainers. In a
narrative review we have summarized the many meta-analyses published in the last 10 years, discussing the role of
confounding and experimental evidence. We also conducted meta-analyses examining episodic heavy drinking
among on average moderate drinkers.
Results: The narrative review showed that the use of current abstainers as the reference group leads to systematic
bias. With regard to average alcohol consumption in relation to lifetime abstainers, the relationship is clearly J-shaped,
supported by short-term experimental evidence and similar associations within strata of potential confounders, except
among smokers. Women experience slightly stronger beneficial associations and also a quicker upturn to a detrimental
effect at lower levels of average alcohol consumption compared to men. There was no evidence that chronic or
episodic heavy drinking confers a beneficial effect on IHD risk. People with alcohol use disorder have an elevated
risk of IHD (1.5- to 2-fold). Results from our quantitative meta-analysis showed that drinkers with average intake of
<30 g/day and no episodic heavy drinking had the lowest IHD risk (relative risk = 0.64, 95% confidence interval
0.53 to 0.71). Drinkers with episodic heavy drinking occasions had a risk similar to lifetime abstainers (relative
risk = 1.12, 95% confidence interval 0.91 to 1.37).
Conclusions: Epidemiological evidence for a beneficial effect of low alcohol consumption without heavy drinking
episodes is strong, corroborated by experimental evidence. However, episodic and chronic heavy drinking do not
provide any beneficial effect on IHD. Thus, average alcohol consumption is not sufficient to describe the risk
relation between alcohol consumption and IHD. Alcohol policy should try to reduce heavy drinking patterns.
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Ischemic heart disease (IHD) is the leading cause of death
and disease burden in the US [1], Europe [2], and globally
[3,4], and alcohol consumption is one of the leading risk
factors for mortality and morbidity [5,6]. There are well-
established risks from neuro-toxic, hepato-toxic, and car-
cinogenic effects caused by alcohol consumption (for
example, the risk for cancers of the upper aerodigestive
tract [7-9], injuries [6,10], and liver cirrhosis [6,10,11]).
However, there has been much debate about a beneficial
effect of alcohol consumption on IHD [12-14]. High
prevalence of both exposure and disease make this ques-
tion a frequent topic among general practitioners, re-
searchers, media, and the public. Aside from numerous
individual studies, several meta-analyses published in the
last decade have summarized the association between al-
cohol consumption and IHD risk.
Most meta-analyses of epidemiological data have shown
a mix between a beneficial and detrimental association
from alcohol consumption on IHD that depends on the
level of average consumption. This relationship is most
often described as curvilinear, or ‘J-shaped’ [15,16], but
also sometimes as a flattened-out inverse association
[15,17,18]. The specific shape of the risk curve seems to
depend at least on sex and IHD outcome (mortality versus
morbidity). Findings of a beneficial effect are supported by
a substantial number of short-term experimental studies
on the effect of alcohol consumption on several surrogate
biomarkers for IHD in a dose-dependent relationship
[19,20], including improved lipid profiles, inhibition of
platelet activation, reduction of fibrinogen levels, and anti-
inflammatory effects. In particular, high density lipopro-
tein (HDL) cholesterol levels have a clear dose-response
relationship with alcohol consumption, with the highest
levels observed in people with the highest alcohol con-
sumption [21,22]. Many criticisms have arisen over the
last three decades questioning the relationship found in
epidemiological studies because of limited quality of alco-
hol assessment, the influence of drinking pattern, adjust-
ment for confounding, or the inability for observational
studies to determine causality [13,23]. Although criteria
for a causal relationship [24] seem to be fulfilled (see also
[15,18]), a direct link for alcohol consumption on IHD risk
from long-term randomized trials is currently, and for the
foreseeable future, missing. Thus, epidemiological studies,
as is the case for many other IHD risk factors, play an im-
portant role in assessing the role of alcohol consumption
on disease risk. The objective of this review is to examine
the evidence available to define the relationship between
alcohol consumption and IHD based mainly on systematic
reviews and meta-analyses, with a focus on the reference
group (that is, the use of lifetime abstainers and not
current abstainers as the reference group because of the
‘sick-quitter’ effect [25]); the influence of drinking pattern(in particular episodic heavy drinking among on average
moderate drinkers [26]); and the influence of several other
important risk factors for IHD, such as age, smoking sta-
tus, physical activity, and body mass index (BMI), all of
which might confound risk estimates for alcohol.
Methods
Searches
Using Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines [27], we con-
ducted two systematic searches in electronic databases
from 1980 up to second week of August. First, we
searched electronic databases for meta-analyses on alcohol
consumption and IHD risk. Second, we searched for ori-
ginal articles, excluding letters, editorials, conference ab-
stracts, reviews, and comments, for variations of search
terms for the exposure (alcohol consumption), outcome
(IHD), and study design based on previous meta-analyses
[15,26]. For details, please see Additional file 1: Text S1,
Figures S1 and S2. Additionally, we hand-searched refer-
ences of identified papers and relevant reviews and meta-
analyses. Using articles reviewed in these two searches, we
examined the role of the reference group, average alcohol
consumption, drinking patterns, confounders, and experi-
mental evidence on the alcohol-IHD relationship in a nar-
rative review, and conducted a quantitative analysis on
drinking patterns among on average moderate alcohol
drinkers in relation to lifetime abstention.
Meta-analysis
Inclusion and exclusion criteria
Inclusion criteria for a quantitative analysis of drinking
patterns in relation to lifetime abstainers were as follows:
adult (≥18 years) population samples; IHD analyzed as a
separate outcome (International Classification of Diseases
(ICD)-9: 410-414, ICD-10: I20-25); case-control, prospect-
ive, or historical cohort study design; alcohol exposure
measurement covering a reference period of more than
2 weeks for average alcohol consumption at baseline; a
drinking group that either specifically excluded or in-
cluded episodic heavy drinking among current drinkers
with an average alcohol consumption <30 g of pure alco-
hol per day; a measure of risk in comparison to lifetime
abstainers and its corresponding measure of variability
was reported (or sufficient data to calculate these); and
English, German, or Spanish language. We excluded self-
reported IHD outcomes and samples from people with
IHD-related conditions.
Data abstraction
For the meta-analyses on drinking patterns in reference
to lifetime abstention, we extracted from all relevant arti-
cles authors’ names, year of publication, country, calendar
year(s) of baseline examination, follow-up period, setting,
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range of age at baseline, sex, number of observed IHD
cases or deaths among participants by drinking group,
number of total participants by drinking group, adjust-
ment for potential confounders, and relative risk (RR) and
its standard error. We used the most adjusted RR re-
ported, and gave priority to estimates comparing drinking
to lifetime abstainers. Information found in related papers
from the same cohort was used where possible. The first
author performed the literature search and abstracted the
data. Full-text articles with potential eligibility were dis-
cussed by both authors until consensus was reached. Pri-
mary authors were not contacted where there was not
enough information presented in the article.
Statistical analysis
Hazard ratios, odds ratios, and RRs were treated as
equivalent measures of risk. If necessary, RRs within stud-
ies were re-calculated based on the method described
by Hamling et al. [28] and pooled across studies using
inverse-variance weighted DerSimonian-Laird random-
effect models to allow for between-study heterogeneity
[29]. We quantified between-study heterogeneity using
Cochran’s Q [30] and the I2 statistic [31]. I2 can be inter-
preted as the proportion of the total variation other than
chance that is due to heterogeneity between studies. We
tested for potential publication bias using Egger’s test [32].
Sensitivity analyses for the influence of single studies on
the pooled RRs were conducted omitting one study at a
time and re-estimating the pooled RR. All meta-analytical
procedures were conducted on the natural log scale in
Stata statistical software, version 12.1 (Stata Corp, College
Station, TX, USA), and P <0.05 (two-sided) was consid-
ered statistically significant.
Results and discussion
In the following paragraphs, we describe the results of
previous systematic reviews and meta-analyses, and indi-
vidual studies on alcohol consumption and IHD risk in a
narrative review. Furthermore, we meta-analyze the role
of heavy drinking patterns in reference to lifetime ab-
stainers using high-quality observational studies.
Lifetime abstainers and former drinkers
The majority of studies on alcohol consumption and IHD
used current abstainers (that is, no current alcohol intake
and no assessment of past alcohol intake) as the reference
group and thus did not distinguish between lifetime ab-
stainers and former drinkers. For almost 30 years this has
been the most important question about the validity of
epidemiological findings on the alcohol-IHD relationship.
Shaper and colleagues put forward the concept of a ‘sick-
quitter’ to describe the elevated risk of many current
abstainers and former drinkers for health outcomes [25].A recent systematic investigation using evidence from 54
epidemiological studies showed that former drinkers were
at higher risk for IHD mortality [33]. The pooled IHD
mortality risk among former drinkers was 1.54 (95% confi-
dence interval (CI) 1.17 to 2.03) in women, and 1.25 (1.15
to 1.36) in men in comparison to lifetime abstainers. The
definition of lifetime abstainers (for example, whether less
than 12 drinks over the lifetime or very infrequent drink-
ing over the lifetime with no more than 12 drinks in a sin-
gle year) did not influence the conclusions about this
effect. However, it should be noted that a distinction be-
tween former drinkers and lifetime abstainers might not
be enough to accurately describe IHD risk among current
non-drinkers. Rogers et al. [34] found that non-drinkers
have different reasons for not drinking and that there is
evidence for heterogeneity among non-drinkers that might
not be captured completely by dividing non-drinkers into
lifetime abstainers and former drinkers.
Average alcohol consumption
Another recent meta-analysis [15] presented the risk of
current drinkers by level of average alcohol intake in
comparison to lifetime abstainers where those estimates
were available and simultaneously adjusting studies
using current abstainers (that is, compensating for the
elevated risk in former drinkers) based on the above-
mentioned meta-analysis. The results clearly showed evi-
dence for a beneficial effect when all available studies
were included regardless of sex and IHD outcome (inci-
dence, mortality, or morbidity). In particular, all pooled
IHD risk estimates were statistically significant for aver-
age alcohol consumption of one to two drinks per day
(point estimates were between 0.69 and 0.81 in compari-
son to lifetime abstainers). The results also showed that
the particular J-shape of the association differed by sex
and IHD outcome in stratified analyses. Sex seems to be
important in that women experience slightly stronger
beneficial associations and also a quicker upturn to a
detrimental effect at lower levels of average alcohol con-
sumption compared to men [15], which might be related
to sex-specific biological factors, such as of body fat dis-
tribution, body size, and alcohol solubility [35-37].
Although some meta-analyses [16,18,38] have reported
a protective association even for chronic heavy alcohol
consumers in population studies (total alcohol intake on
average ≥60 g pure alcohol/day), these results need to be
interpreted with caution because the reference group is
of crucial importance, as shown above. The association
seems beneficial among chronic heavy drinkers only
when the reference group comprises current abstainers
(that is, lifetime abstainers and former drinkers). For
example, Ronksley et al. [18] reported a pooled RR of
0.76 (95% CI 0.52 to 1.09) for IHD incidence and 0.75
(95% CI 0.63 to 0.89) for IHD mortality among chronic
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non-drinkers.
Most recently, a systematic review and meta-analysis
[39] demonstrated that chronic heavy drinking does not
show any beneficial association with IHD risk when life-
time abstainers are the reference group. IHD mortality
risk among male chronic heavy drinkers (≥60 g/day) was
similar to lifetime abstainers with no indication for a
protective association (RR = 1.00, 95% CI 0.74 to 1.36).
Similarly, IHD incidence (that is, using both mortality
and morbidity outcomes) showed no indication of a pro-
tective effect (RR = 1.04, 95% CI 0.83 to 1.31) [39]. Such
chronic heavy drinking is rarely observed in women in
population studies and there are not enough studies to sys-
tematically investigate chronic heavy drinking compared
to lifetime abstention in women. The above-mentioned
IHD mortality risks of average alcohol consumption
among men in comparison to lifetime abstainers using
data from several previous meta-analyses are displayed
in Figure 1.
Whereas the aforementioned investigations were con-
ducted using data from population studies, evidence
from clinical samples involving patients with alcohol use
disorder (AUD) in alcohol treatment showed a detri-
mental association with IHD mortality in both men
and women (RR = 1.62, 95% CI 1.34 to 1.95 in men and
RR = 2.09, 95% CI 1.28 to 3.41 in women compared to the
general population, see also [42]) in a recent meta-analysis
[39]. Patients with AUD are typically missed or underrep-
resented in population studies [43].
Among those reporting the strongest elevated risk
for IHD are studies from Russia [40,41]. These studies
consistently report substantially elevated RRs in heavy
drinkers; however, alcohol consumption seems so prevalentFigure 1 The association of ischemic heart disease mortality with ave
men. Data points taken from published meta-analyses [15,33,39]. All point
meta-analyses stratified by alcohol exposure. The Russian estimates were pin Russia that there have not been enough lifetime ab-
stainers to define the risk relationship in comparison to
zero alcohol intake over the life course. Nevertheless, the
risk among heavy alcohol drinkers in comparison to low-
level drinkers [40,41] was substantial (Figure 1).
Although no reliable comparisons exist because life-
time abstention is rare in Russia, one can speculate
whether the estimates for heavy drinking are over- or
underestimates compared to lifetime abstainers. Assum-
ing the reference group (0.2 half-liter bottles of vodka
per week or 4.6 g/day on average) has a similar risk
compared to low-level drinkers elsewhere (RR = 0.81),
the adjusted risk would be 1.58 (95% CI 1.48 to 1.69),
only slightly less than assuming the risk among on aver-
age low-level drinkers in Russia is indeed equal to that
of lifetime abstainers elsewhere (RR = 1.00, Figure 1).
However, given the heavy episodic drinking pattern com-
mon in Russia, one would not necessarily expect to find
any beneficial effect from any alcohol consumption on
IHD risk on a population level as we argue below. Simi-
larly, if one assumes a beneficial effect from average
moderate alcohol consumption for 25% of the population,
the risk in male patients with AUD would be slightly less
(RR = 1.36, 95% CI 1.13 to 1.64). In summary, the relation-
ship between average alcohol consumption and IHD risk
is clearly J-shaped with an increased IHD risk at high
levels of alcohol consumption when compared to lifetime
abstainers or low-level drinkers.
Drinking pattern
Alcohol can be consumed in many different ways, lead-
ing to the concern that an episodic heavy drinking pat-
tern may confound or modify the relationship seen for
average volume of alcohol intake and IHD risk [44,45].rage alcohol consumption in comparison to lifetime abstention in
estimates and confidence intervals were obtained from categorical
ooled from Zaridze et al. [40,41].
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fied risk matrix by amount of alcohol consumption on
drinking days and frequency of such drinking days, in the
Australian part of the MONICA project looking at myo-
cardial infarction risk [46]. Since then, several other studies
have examined the alcohol-IHD relationship with similar
detail, making it possible to investigate the influence of
drinking patterns more systematically. Excluding the po-
tential problem of lifetime abstainers and former drinkers,
a recent meta-analysis examined drinking patterns among
current drinkers who were not chronic heavy drinkers
(that is, excluding those with average total alcohol intake
of ≥60 g/day) [26]. This meta-analysis found a significant
difference when comparing episodic heavy drinkers with
moderate regular drinkers, with a pooled RR = 1.45 (95%
CI 1.24 to 1.70). Other studies published since then have
shown similar findings [33,47].
Meta-analysis on drinking pattern among moderate alcohol
drinkers
In a quantitative meta-analysis paying special attention
to the effects of alcohol consumption patterns, we sys-
tematically examined IHD risk among two distinct
drinking groups with the same average alcohol intake
(Figure 2). We identified seven studies providing data on
episodic heavy drinking at low to moderate average alcohol
consumption (<30 g/day) in comparison to lifetime ab-
stainers (Additional file 1: Table S1, Figures S3 and S4).
Compared with lifetime abstainers (that is, not including
former drinkers), the pooled RR for IHD incidence was
0.64 (95% CI 0.53 to 0.71) for moderate drinkers without
heavy drinking occasions, and 1.12 (95% CI 0.91 to 1.37)
for drinkers with the same average amount who engaged
in heavy episodic drinking (Figure 2, Additional file 1:
Table S1, Figures S3 and S4). There was no evidence for
publication bias (P = 0.35 and 0.58 for moderate non-heavy
drinkers and episodic heavy drinkers, respectively). NoneFigure 2 Ischemic heart disease incidence by drinking pattern among
to lifetime abstention. Please see Additional file 1: Table S1, Figures S3 anof the primary studies in the two meta-analyses had a large
influence on the pooled RR estimates. Furthermore, there
was very little heterogeneity (10% and 0%, respectively). All
studies were adjusted for age and smoking status, five for
education and other indicators for socio-economic status,
and four each for BMI and marital status.
The corresponding RR between these two drinking
groups was 1.75 (95% CI 1.36 to 2.25), higher than the
estimate from the previous meta-analysis [26]. In other
words, the impact of episodic heavy drinking seems to
be greatest at low levels of average alcohol consumption
in studies that have separated lifetime abstainers from
former drinkers and were well-adjusted for the most
relevant potential confounders (Additional file 1: Table S1).
Furthermore, the risk estimate for non-heavy low-level
drinking was lower (that is, stronger in magnitude for a
beneficial effect) than previous investigations of average al-
cohol consumption without taking into account episodic
heavy drinking occasions [15,18].
Studies from Russia
The importance of drinking patterns becomes particularly
important when looking at Russian studies [40,48-50].
A relatively frequent consumption pattern in Russia is epi-
sodic heavy to very heavy consumption with sometimes
prolonged binges (‘zapoi’, an episode of continuous drunk-
enness lasting two or more days in combination with
withdrawal from normal social life [51]). This drinking
pattern is so extreme that it is heavy with regard to
both average and episodic consumption. For example
Malyutina et al. [48] in the Russian component of the
MONICA project reported that only 7% of their sample
drank 40 g pure alcohol or less per typical occasion. More-
over, 12% of this Russian sample were current abstainers,
55% reported drinking 80 g or more per typical occasion,
and only 8% had a drinking frequency of more than
two days per week. In comparison, the National Healthdrinkers with average consumption of <30 g/day in comparison
d S4 for details. †Taken from Roerecke & Rehm [26].
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stainers, 15% former drinkers, 42% infrequent or moderate
drinkers, and only 27% of the participants drank three or
more drinks (≥36 g pure alcohol) per drinking day [52].
There is substantial epidemiological evidence showing
no protective effect on IHD risk from episodic heavy
drinking, whereas the evidence for a beneficial effect of
alcohol is substantial and strongest among non-heavy
low-level drinkers. In summary, drinking patterns have
modifying effects on the relationship between average al-
cohol consumption and IHD risk.
Confounding from other risk factors for ischemic heart
disease
Residual confounding is an issue for all risk factors for
IHD in observational studies. Many risk factors for IHD
have been identified [1]. Inclusion of potential confounders
had little influence on the pooled risk estimates from
meta-analyses examining drinking versus non-drinking sta-
tus [18]; this finding was similar within categories of aver-
age alcohol consumption in a pooled individual-data
analysis of eight cohort studies (confounders included age;
year of baseline; smoking; BMI; education; physical activity;
energy intake; intake of polyunsaturated fat, monounsatu-
rated fat, saturated fat, fiber, and cholesterol; and study de-
sign) [53]. Aside from adjustment for confounding, many
studies have reported stratified analyses by important risk
factors for IHD, which we detail below.
Age
Hvidtfeldt et al., in a pooled individual-level analysis,
showed an inverse relationship for each sex and each of
three age groups based on eight cohort studies with
250,000 participants [53]. An inverse relationship based
on 64,000 participants stratified into below 60 years of
age and 60 years or above has been shown in Chinese
men [54]. An analysis of the male British Doctors cohort
found an inverse relationship both among participants
younger than 75 years and those 75 years and above
[55]. In a case-control study from Japan, Miyake found
an inverse relationship both among participants younger
than 65 years and those 65 years and above [56]. A case-
control study from Portugal showed a U-shape in those
under 45 years of age and an elevated risk only in study
participants drinking more than 60 g of alcohol per day
among participants 45 years or older [57]. The Honolulu
Heart Program cohort showed an inverse relationship
both among participants aged between 51 and 65 years
and those 65 to 75 years old [58].
Smoking
Although numerous modifiable risk factors for IHD have
been identified, their influence on the alcohol-IHD rela-
tionship seems to be small, except for smoking. Smokingis, aside from age, the most important risk factor for
IHD, and several studies have provided evidence on its
influence on the alcohol-IHD relationship. It should be
noted that alcohol is one of the most investigated risk
factors for IHD [59]. Inoue et al., in a pooled individual
analysis by smoking status, showed a J-shape in never
smokers and a U-shape in current smokers, with the
highest category of average alcohol consumption being
92 g/day or more in 300,000 Japanese participants [60].
A Chinese cohort study showed a similar inverse rela-
tionship in both current smokers and current non-
smokers [54]. An inverse relationship among never
smokers, a U-shape in former smokers, and an expo-
nential relationship in current smokers was reported in
a male Scottish sample of factory workers between 35
and 64 years old and with 30 years of follow-up [61].
Ebbert et al. showed an inverse relationship among
never smokers and former smokers, and no relationship
among current smokers in a low consumption cohort -
the Iowa Women’s Health study [62]. An analysis of the
Framingham study with 24 years of follow-up showed
an inverse relationship among non-smokers, no rela-
tionship among light smokers (≤1 pack/day), and an in-
verse relationship among heavy smokers (>1 pack/day)
in men. In women, a U-shape was found among non-
smokers and smokers [63]. An analysis of the British
Regional Heart Study showed an inverse relationship
among former smokers, no relationship among current
smokers, and an unclear relationship among never
smokers. However, there were too few IHD deaths among
never drinkers to reach a firm conclusion [64]. In an in-
vestigation of the National Health and Nutrition Examin-
ation Survey (NHANES I) in women 45 to 74 years old,
an inverse relationship in both smokers and non-smokers
was reported [65].
In sum, regarding average alcohol consumption, in all
but one population study an inverse or J-shaped curve was
observed in never or non-smokers. Evidence in smokers
is mixed. Some studies reported an inverse relationship,
some a threshold relationship, and some no clear rela-
tionship. Regarding clinical samples of patients in AUD
treatment, there is the possibility that the detrimental
association from alcohol consumption is overestimated
because of uncontrolled confounding from smoking in
these samples. However, the prospective Russian study
by Zaridze et al. [41] clearly showed a substantially
increasing risk with increasing alcohol consumption
among male smokers.
Other confounding factors
Some evidence stratified by physical activity and BMI
for the alcohol-IHD relationship exists. Pedersen et al.
investigated fatal IHD in the Copenhagen City Heart
Study [66]. They found an inverse relationship for both
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in a low consumption cohort. The risk for non-drinkers
and drinkers having less than one drink per week was
consistently higher compared to drinkers having one to
14 drinks per week and 15 or more drinks. They con-
cluded that both physical activity and alcohol consump-
tion were factors for lower IHD risk. Bazzano et al.
found an inverse relationship for participants with a
BMI ≥25 and <25, with stronger evidence among those
with a BMI <25 [54].
In sum, the epidemiological evidence shows that only
in smokers there is some evidence that there is no bene-
ficial association of alcohol consumption, and possibly a
threshold effect, pointing to possible effect modification
with alcohol consumption. Evidence for a beneficial as-
sociation was consistent across age groups and in non-
smokers. Available evidence for the influence of physical
activity and BMI is sparse, although this evidence points
to a beneficial association, as well. Furthermore, a bene-
ficial association has been observed in patients who are
hypertensive, diabetic, have cardiovascular diseases, and
who are survivors of myocardial infarction [67-73]. An
inverse relationship has been observed in healthy indi-
viduals in a US cohort [74], and no association in a UK
cohort [75].
Experimental evidence
Long-term randomized studies on alcohol exposure and
IHD mortality or morbidity in the general population
are unavailable. Regular alcohol intake has been found
to have beneficial, dose-dependent effects on surrogate
biomarkers for IHD risk in short-term experimental
studies, mainly by increasing HDL cholesterol levels,
inhibiting platelet activation, reducing fibrinogen levels,
and producing anti-inflammatory effects [19,76]. The in-
crease in HDL cholesterol was also evident in experi-
mental studies with regular heavy drinking (≥60 g/day
every day) [77-82], and the highest levels of HDL choles-
terol are found in people with AUD [21]. Despite ele-
vated levels of HDL cholesterol even in regular heavy
alcohol consumers [83], an increase in low-density lipo-
protein (LDL) and other detrimental effects of episodic
and chronic heavy alcohol consumption on heart disease
risk seem to negate those beneficial effects, resulting
in an overall neutral or detrimental association. The
detrimental effect on blood pressure and arrhythmias
[44,84-90] and atrial fibrillation [44,89,91-93], in particu-
lar from episodic and chronic heavy drinking, might play
a role here, in combination with anti-atherosclerotic
and anti-thrombotic processes. Although systematic ex-
perimental evidence for the effect of episodic heavy
drinking is limited, the biochemical effects might in-
volve HDL and LDL cholesterol levels, arrhythmias, and
thrombosis [45]. It seems that episodic heavy drinkingincreases LDL cholesterol levels without a favorable effect
on HDL [45], and possibly a transient detrimental effect on
thrombosis, hypertension, and arrhythmias [44,45]. Pro-
longed chronic heavy drinking can result in the most ex-
treme form of cardiac tissue damage, cardiomyopathy [94].
Recently, using Mendelian randomization, Holmes
et al. [95] examined the impact of alcohol dehydrogen-
ase 1B alleles on IHD risk, and concluded that for every
level of alcohol consumption, an increase in average
consumption was associated with an increase in IHD
risk, that is, no protective effect. The rs1229984 A-allele
is associated with lower alcohol consumption due to
negatively experienced effects (including a flushing re-
sponse) caused by the fast metabolization of alcohol into
acetaldehyde [96]. This study design can be seen as
quasi-randomized, assuming the rs1229984 A-allele is
randomly distributed in the population, thus non-
carriers having the same IHD risk aside from the effect
of the rs1229984 A-allele. An additional assumption has
to be for conclusions regarding the absence of a protect-
ive effect that the effect of the polymorphism is entirely
mediated via average alcohol consumption. However,
Holmes et al. showed that, aside from the association
with lower average alcohol consumption, the rs1229984
A-allele was also related to less binge drinking. As we
have shown above, both average alcohol consumption
and drinking patterns interact in a complex way with
regard to IHD risk, and the alcohol-heart relationship
cannot be accurately described using only one of the di-
mensions of alcohol intake. Taken together, it is difficult
to compare the results from Holmes et al. to the epi-
demiological literature we have described here. Never-
theless, Mendelian randomization studies may become a
very useful tool in widening the evidence base for a
causal relation between alcohol consumption and IHD
risk, together with both observational and experimental
studies on the specific effects of drinking patterns on the
heart (please see also [97]).
Thus, there is substantial experimental evidence for a
beneficial effect of low to moderate regular alcohol con-
sumption on IHD, which disappears for episodic heavy
drinking. Novel study designs may help in improving
knowledge of the complex relationship between alcohol
and IHD risk.
Conclusions
Alcohol’s effect on the human body and mind is quite
strong, even at low doses [98]. Its neuro-toxic, hepato-
toxic, and carcinogenic properties make it a potent risk
factor for disease burden. However, its effect on IHD
risk also makes it an intriguing and sometimes contro-
versial topic in disease epidemiology and public policy.
The quality of epidemiological studies has substantially
improved over the last three decades. Using current abstainers
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ous conclusions. Using high-quality epidemiological evi-
dence, a clear picture supported by short-term experimental
evidence emerges. When examining average alcohol con-
sumption in comparison to lifetime abstainers, the relation-
ship with IHD risk follows a J-curve. The curve turns into a
detrimental association for much lower average alcohol
levels in women compared with men.
However, average alcohol consumption alone is not suf-
ficient to describe the alcohol-IHD relationship. Drinking
patterns play an important role and both episodic and
chronic heavy drinking negate any beneficial association
with IHD risk, or elevate the risk substantially. Neverthe-
less, for drinkers having one to two drinks per drinking
day without episodic heavy drinking, there is substantial
and consistent evidence from epidemiological and short-
term experimental studies for a beneficial association
with IHD risk when compared to lifetime abstainers. The
alcohol-IHD relationship fulfills all criteria for a causal as-
sociation proposed by Hill [24]. Whether one is able to
detect an inverse, U-shaped, or J-shaped relationship de-
pends on the distribution of drinking pattern in a given
population. Prevalence of heavy drinking patterns has
been on the rise in many countries, such as Canada, the
US, the UK, and many Eastern European and Asian coun-
tries [99-102]. In the US, episodic heavy drinking is more
common than chronic heavy drinking [102].
Aside from any effect on IHD, caution must be used
when judging the overall risk-benefit relationship of any
form of alcohol consumption on an individual level be-
cause of well-known detrimental effects on other disease
outcomes, such as injuries and cancer [6,7,103]. Recom-
mendations for clinical practitioners (aside from clear
contra-indications because of other illnesses or medication
intake) remain challenging because of the apparent simul-
taneous beneficial and detrimental effects from on average
low alcohol consumption, and the fact that evidence from
randomized controlled trials on long-term effects of alco-
hol consumption is and will be unavailable. Furthermore,
there is no control mechanism for alcohol purchase as
there is for prescription drugs because alcohol is freely
available for self- and over-medication. Therefore, uptake
of alcohol consumption should not be considered as a
treatment option in prevention of IHD. In terms of public
alcohol policy, the picture is clear: alcohol consumption
should be as low as possible, no amount of consumption
is safe, and any type of episodic and chronic heavy drink-
ing should be strongly discouraged [104,105].
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